Breast Cancer Coverage from Every Angle

Hope S. Rugo, MD, on Immunotherapy Combinations for Breast Cancer

Posted: Wednesday, January 2, 2019

Hope S. Rugo, MD, of the University of California, San Francisco, discusses new immunotherapy drug combinations, predictive factors, and the immune microenvironment, and how they relate to the NCCN Guidelines.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.